What is GelX®?
GelX® is an oral spray, designed to protect the mucous membranes within the mouth. It is indicated for the prevention and treatment of oral mucositis and is suitable for use in all ages and all ethnic cultures.1
How it works ?
GelX® works by providing a barrier to protect oral membrane tissue. It blocks exposed nerve endings and coats oral lesions to soothe and relieve pain.1,2 This helps patients to cope with oral mucositis and to complete long-term treatment goals.3
Clinically Proven
- Prevention of OM was achieved in 37.24% of patients. Of the remaining patients who did experience OM symptoms, 93.4% had a complete remission of their symptoms.3
- GelX® reduces the need to interrupt chemotherapy or radiotherapy treatment due to oral mucositis.3
- The use of GelX® in the prevention and soothing of cancer-therapy-induced oral mucositis has been clinically proven in children and adults suffering from a variety of malignancies.3,4,5
What is Oral Mucositis?
Oral mucositis, a common side effect of certain medical treatments like chemotherapy and radiation therapy, can be an incredibly distressing condition characterized by inflammation and ulceration of the oral tissues. This debilitating condition often leads to severe pain and discomfort, significantly impacting an individual’s ability to eat, speak, and carry out everyday activities.
References
- GelX Oral Spray Instructions for Use.
- Biswal BM. Current trends in the management of oral mucositis related to cancer treatment. Malaysian J Med Sci. 2008; 15(3):4-13. Ld.
- Niculita O. et al. The efficacy of polyvinylpyrrolidone-Zn Gluconate and Taurine in the prevention of Oral Mucositis in Haematological Patients. Rev. Chim., 71 (8), 2020, 195-205
- Colita, A. et al. Single-center, open-label safety and efficacy. The efficacy of PVP-zinc gluconate and taurine gel (GelX) in prophylaxis and treatment of oral mucositis in children treated with chemotherapy. 15 patients GelX Oral Spray Poster at EHA, June 2015. Vienna.
- Dragomir, M. Single-center, open-label safety and efficacy ongoing study. Prevention and treatment of chemotherapy-induced oral mucositis in children with cancer. 15 patients treated with GelX Oral Spray. Poster presented at the ECCO Congress, Sep 2015. Vienna